Literature DB >> 31298473

Older Donor Age Is a Risk Factor for Negative Outcomes After Adult Living Donor Liver Transplantation Using Small-for-Size Grafts.

Mahmoud Macshut1,2, Toshimi Kaido1, Siyuan Yao1, Shintaro Yagi1, Takashi Ito1, Naoko Kamo1, Kazuyuki Nagai1, Mohamed Sharshar1,2, Shinji Uemoto1.   

Abstract

Adult-to-adult living donor liver transplantation (ALDLT) using small-for-size grafts (SFSGs), ie, a graft with a graft-to-recipient weight ratio (GRWR) <0.8%, has been a challenge that should be carefully dealt with, and risk factors in this category are unclear. Therefore, we aimed to examine the risk factors and outcomes of ALDLT using SFSGs over a 13-year period in 121 patients who had undergone their first ALDLT using SFSGs. Small-for-size syndrome (SFSS), early graft loss, and 1-year mortality were encountered in 21.6%, 14.9%, and 18.4% of patients, respectively. By multivariate analysis, older donor age (≥45 years) was an independent risk factor for SFSS (odds ratio [OR], 4.46; P = 0.004), early graft loss (OR, 4.11; P = 0.02), and 1-year mortality (OR, 3.76; P = 0.02). Child-Pugh C class recipients were associated with a higher risk of SFSS development (P = 0.013; OR, 7.44). Despite no significant difference between GRWR categories in the multivariate outcome analysis of the whole population, in the survival analysis of the 2 donor age groups, GRWR <0.6% was associated with significantly lower 1-year survival than the other GRWR categories in the younger donor group. Moreover, in the high final portal venous pressure (PVP) group (>15 mm Hg), younger ABO-compatible donors showed 100% 1-year survival with a significant difference from the group of other donors. Older donor age was an independent risk factor for SFSS, early graft loss, and 1-year mortality after ALDLT using SFSGs. GRWR should not be <0.6%, and PVP modulation is indicated when grafts from older or ABO-incompatible donors are used.
Copyright © 2019 by the American Association for the Study of Liver Diseases.

Entities:  

Year:  2019        PMID: 31298473     DOI: 10.1002/lt.25601

Source DB:  PubMed          Journal:  Liver Transpl        ISSN: 1527-6465            Impact factor:   5.799


  4 in total

1.  Comparison of liver regeneration between donors and recipients after adult right lobe living-donor liver transplantation.

Authors:  Yuling Zhang; Bei Li; Qing He; Zhiqiang Chu; Qian Ji
Journal:  Quant Imaging Med Surg       Date:  2022-06

Review 2.  Conceptual changes in small-for-size graft and small-for-size syndrome in living donor liver transplantation.

Authors:  Toru Ikegami; Jong Man Kim; Dong-Hwan Jung; Yuji Soejima; Dong-Sik Kim; Jae-Won Joh; Sung-Gyu Lee; Tomoharu Yoshizumi; Masaki Mori
Journal:  Korean J Transplant       Date:  2019-12-31

3.  Successful Simultaneous Subtotal Splenectomy During Left Lobe Auxiliary Liver Transplantation for Portal Inflow Modulation and Severe Hypersplenism Correction: A Case Report.

Authors:  Guang-Peng Zhou; Wei Qu; Zhi-Gui Zeng; Li-Ying Sun; Ying Liu; Lin Wei; Zhi-Jun Zhu
Journal:  Front Med (Lausanne)       Date:  2022-01-31

4.  Comment on experience with LDLT in patients with hepatocellular carcinoma and portal vein tumor thrombosis postdownstaging.

Authors:  Sami Akbulut; Tevfik Tolga Sahin
Journal:  Int J Surg Case Rep       Date:  2020-07-28
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.